Association of serum apolipoprotein C III levels and apolipoprotein C III gene Sst I polymorphism with carotid intima-media thickness in Chinese type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 66, Issue 1, 2004, Pages 41-47

  Chen, Xiang ^a   Tian, Haoming ^a   Liu, Rei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Apolipoprotein C III; Carotid intima media thickness; Sst I polymorphism; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; APOLIPOPROTEIN C; CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DIABETIC NEUROPATHY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DNA POLYMORPHISM; FEMALE; HUMAN; INTIMA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; THICKNESS; TRIACYLGLYCEROL BLOOD LEVEL; TUNICA MEDIA;

APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; BLOOD GLUCOSE; CAROTID ARTERIES; CAROTID STENOSIS; CHINA; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; INSULIN; LIPIDS; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 4444381913     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2004.02.020     Document Type: Article

References (24)

1. T.C. Fagan, Scowers, Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy, Arch. Inter. Med. 159 (1999) 1033-1034.
2. Davis T.M., Millns H., Stratton I.M., et al. Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch. Intern. Med. 159:1999;1097-1103
3. Wick U., Witt E., Engel W. Restriction fragment length polymorphisms at the apoprotein genes A I, C III and B-100 and in the 5′ flanking region of the insulin gene as possible markers of coronary heart disease. Clin. Genet. 47:1995;184-190
4. Lorenzo F.D., Rubba P., Monticelli A., et al. Coronary heart disease, echo-doppler evidence of peripheral arterial disease and polymorphism of apolipoprotein B gene and apoA I/C III cluster. Angiology. 44:1993;785-790
5. Russo G.T., Meigs J.B., Cupples L.A., et al. Association of the Sst-I polymorphism at the apoC3 gene locus with variations in lipid levels. Atherosclerosis. 158:2001;173-181
6. Salonen J.T., Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterio. Throm. 11:1991;1245-1249
7. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complication. Part 1. Diagnosis and Classification of Diabetes Mellitus, World Health Organization, Geneva, 1999.
8. Fan P., Liu B. Study on lipid and apolipoprotein composition of plasma VLDL, LDL and HDL in endogenous hypertriglyceridemia. J. West China Univ. Med. Sci. 26:1995;6-10
9. H.A. Erlich, 1989, PCR Technology: Principles and Applications for DNA Amplification, first ed., Stockton Press, New York.
10. Ren Y., Tian H., Liu R., et al. Apo C III gene polymorphism in type 2 diabetic mellitus with hypertriglyceridemia. Chin. J. Endocrinol. Metab. 16:2000;220-223
11. Onat A., Hergenc G., Sansoy V., et al. Apolipoprotein C III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. Atherosclerosis. 168:2003;81-89
12. Blankenhorn D.H., Nessim S.A., Johnson R.L., et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 257:1987;3233-3240
13. Blankenhorn D.H., Azen S.P., Kramsch D.M., et al. Coronary angiographic changes with lovastatin therapy: the Monitored Atherosclerosis Regression Study (MARS). Ann. Intern. Med. 119:1993;969-976
14. Blankenhorn D.H., Selzer R.H., Crawford D.W., et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery: two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation. 88:1993;2-28
15. Hodis H.N., Mack W.J., LaBree L., et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy. Ann. Intern. Med. 124:1996;548-556
16. Maeda N., Li H., Lee D., et al. Targeted disruption of the apolipoprotein C III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J. Biol. Chem. 269:1995;23610-23616
17. Ito Y., Azrolan N., O'Connell A., et al. Hypertriglyceridemia as a result of human apo C III gene expression in transgenic mice. Science. 249:1990;790-793
18. Aalto-Setala K., Fisher E.A., Chen X., et al. Mechanism of hypertriglyceridemia in human apolipoprotein C III transgenic mice. J. Clin. Invest. 90:1992;1889-1890
19. Ebara T., Ramakrishnan R., Steiner G., et al. Chylomicronemia due to apolipoprotein C III overexpression in apolipoprotein E-null mice. J. Clin. Invest. 99:1997;2672-2681
20. Cohn J.S., Batal R., Tremblay M., et al. Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism. J. Lipid Res. 44:2003;1976-1983
21. Marcoux C., Tremblay M., Fredenrich A., et al. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins. Metabolism. 50:2001;112-119
22. Bruns G.A., Karanthasis S.K., Breslow J.L. Human apolipoproteinA I-C III gene complex is located on chromosome 11. Arteriosclerosis. 4:1984;97-102
23. Humphries S.E. DNA polymorphism of the apolipoprotein genes-their use in the investigation of the genetic component of hyperlipidemia and atherosclerosis. Atherosclerosis. 72:1988;89-108
24. Choi G.R., Suh S.P., Song J.W., et al. Genetic variation of the apoA I-C III-AIV gene cluster in hypertriglyceridemic patients with chronic renal failure undergoing hemodialysis. J. Korean Med. Sci. 15:2000;289-294